Free Trial

Quipt Home Medical Corp. (NASDAQ:QIPT) VP Acquires $41,650.00 in Stock

Quipt Home Medical logo with Medical background

Quipt Home Medical Corp. (NASDAQ:QIPT - Get Free Report) VP Patrick Dennis Gamble bought 17,000 shares of the stock in a transaction dated Thursday, December 26th. The stock was purchased at an average price of $2.45 per share, with a total value of $41,650.00. Following the acquisition, the vice president now owns 40,057 shares of the company's stock, valued at $98,139.65. The trade was a 73.73 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Quipt Home Medical Stock Up 7.7 %

NASDAQ:QIPT traded up $0.20 on Monday, hitting $2.80. The stock had a trading volume of 438,191 shares, compared to its average volume of 194,691. Quipt Home Medical Corp. has a 1 year low of $2.30 and a 1 year high of $5.26. The firm's fifty day simple moving average is $2.63 and its two-hundred day simple moving average is $2.91. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.77 and a current ratio of 1.11. The stock has a market cap of $120.65 million, a P/E ratio of -25.45 and a beta of 0.62.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its quarterly earnings results on Monday, December 16th. The company reported ($0.07) EPS for the quarter, missing analysts' consensus estimates of $0.01 by ($0.08). Quipt Home Medical had a negative net margin of 1.95% and a negative return on equity of 4.51%. Analysts predict that Quipt Home Medical Corp. will post -0.1 earnings per share for the current year.

Institutional Investors Weigh In On Quipt Home Medical

A number of hedge funds have recently made changes to their positions in QIPT. JPMorgan Chase & Co. grew its position in Quipt Home Medical by 68.7% during the third quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company's stock valued at $89,000 after buying an additional 12,383 shares during the period. Franklin Resources Inc. grew its position in shares of Quipt Home Medical by 8.7% during the 3rd quarter. Franklin Resources Inc. now owns 740,785 shares of the company's stock valued at $2,163,000 after acquiring an additional 59,441 shares during the period. Barclays PLC increased its stake in shares of Quipt Home Medical by 79.2% during the 3rd quarter. Barclays PLC now owns 87,425 shares of the company's stock worth $256,000 after purchasing an additional 38,635 shares during the last quarter. Forager Capital Management LLC raised its holdings in shares of Quipt Home Medical by 77.7% in the 3rd quarter. Forager Capital Management LLC now owns 4,192,562 shares of the company's stock worth $12,200,000 after purchasing an additional 1,833,590 shares during the period. Finally, XTX Topco Ltd purchased a new position in Quipt Home Medical in the third quarter valued at approximately $54,000. 42.85% of the stock is currently owned by institutional investors.

About Quipt Home Medical

(Get Free Report)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Quipt Home Medical right now?

Before you consider Quipt Home Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.

While Quipt Home Medical currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Rivian Stock Surge Analysis: Long-Term Potential or Short-Term Play?
The Future of Healthcare: 3 AI Stocks Leading the Way
Analysts Predict Big Gains for These 3 Cybersecurity Leaders

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines